N-(3-(4-Methylpiperazin-1-Yl)Phenyl)-8-(4-(Methylsulfonyl)Phenyl)-[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-a]吡啶-2-胺
CAS 1257704-57-6 MFCD357704576
化学结构图
SMILES: CN1CCN(c2cccc(Nc3nc4c(-c5ccc(S(C)(=O)=O)cc5)cccn4n3)c2)CC1
化学属性
| Mol. Weight | 462.57 |
|---|---|
| Appearance | Solid powder |
| Solubility | Soluble in DMSO, not in water |
别名和识别编码
| Chemical Name Translation | N-[3-(4-甲基-1-哌嗪基)苯基]-8-[4-(甲磺酰基)苯基]-[1,2,4]三唑并[1,5-a]吡啶-2-胺 |
|---|---|
| Chemical Name | N-(3-(4-Methylpiperazin-1-Yl)Phenyl)-8-(4-(Methylsulfonyl)Phenyl)-[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine |
| Formula | C24H26N6O2S |
| Synonym | CEP33779; CEP-33779; CEP 33779. |
| IUPAC Name | N-(3-(4-methylpiperazin-1-yl)phenyl)-8-(4-(methylsulfonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine |
| InChIKey | RFZKSQIFOZZIAQ-UHFFFAOYSA-N |
| InChI | InChI=1S/C24H26N6O2S/c1-28-13-15-29(16-14-28)20-6-3-5-19(17-20)25-24-26-23-22(7-4-12-30(23)27-24)18-8-10-21(11-9-18)33(2,31)32/h3-12,17H,13-16H2,1-2H3,(H,25,27) |
| Canonical SMILES | O=S(C1=CC=C(C2=CC=CN3C2=NC(NC4=CC=CC(N5CCN(C)CC5)=C4)=N3)C=C1)(C)=O |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
产品应用
- CEP-33779 is a highly selective, orally active, small-molecule inhibitor of JAK2. CEP-33779 induced regression of established colorectal tumors, reduced angiogenesis, and reduced proliferation of tumor cells. Tumor regression correlated with inhibition of STAT3 and NF-κB (RelA/p65) activation in a CEP-33779 dose-dependent manner. The ability of CEP-33779 to suppress growth of colorectal tumors by inhibiting the IL-6/JAK2/STAT3 signaling suggests a potential therapeutic utility of JAK2 inhibitors in multiple tumors types, particularly those with a strong inflammatory component.
